Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency
Seminars in Liver Disease · 2023-08 · 43 (03) · 258-266
DOI: 10.1055/a-2122-7674 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, online erschienen am 09.08.2023. Verfasst von Mathias Ruiz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hépatologie, Gastroentérologie et Nutrition Pédiatriques, Hôpital Femme Mère Enfant, Hospices civils de Lyon, Health Care Provider of the European Re…. Hauptthemen laut MEDLINE: alpha 1-Antitrypsin Deficiency, Cholestasis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft (DFG).
Abstract (Originalsprache)
Alpha-1 antitrypsin deficiency (AATD) arises due to inherited variants in SERPINA1, the AAT gene that impairs the production or secretion of this hepatocellular protein and leads to a gain-of-function liver proteotoxicity. Homozygous Pi*Z pathogenic variant (Pi*ZZ genotype) is the leading cause of severe AATD. It manifests in 2 to 10% of carriers as neonatal cholestasis and 20 to 35% of adults as significant liver fibrosis. Both children and adults may develop an end-stage liver disease requiring liver transplantation. Heterozygous Pi*Z pathogenic variant (Pi*MZ genotype) constitutes an established disease modifier. Our review summarizes the natural history and management of subjects with both pediatric and adult AATD-associated liver disease. Current findings from a phase 2 clinical trial indicate that RNA silencing may constitute a viable therapeutic approach for adult AATD. In conclusion, AATD is an increasingly appreciated pediatric and adult liver disorder that is becoming an attractive target for modern pharmacologic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Hépatologie, Gastroentérologie et Nutrition Pédiatriques, Hôpital Femme Mère Enfant, Hospices civils de Lyon, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Lyon, France.
- Service de Gastroentérologie-Nutrition Pédiatriques et Unité d'Hépatologie Pédiatrique Hôpital Universitaire Necker-Enfants Malades, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RA…
- Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germ…
- Liver Unit, Hospital Universitari Vall d'Hebron, Vall d'Hebron Research Institute (VHIR), Universitat Autonoma de Barcelona, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER…
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
- The Children's Memorial Health Institute, Department of Gastroenterology, Hepatology, Nutritional Disorders and Pediatrics, Al. Dzieci Polskich, Warszawa, Poland.
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Ruiz, M., Lacaille, F., Schrader, C., Pons, M., Socha, P., Krag, A., Sturm, E., Bouchecareilh, M., & Strnad, P. (2023). Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency. Seminars in Liver Disease, 43(03), 258-266. https://doi.org/10.1055/a-2122-7674
Vancouver
Ruiz M, Lacaille F, Schrader C, Pons M, Socha P, Krag A, et al. Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency. Seminars in Liver Disease. 2023;43(03):258-266. doi:10.1055/a-2122-7674
BibTeX
@article{Ruiz2023,
author = {Ruiz, Mathias and Lacaille, Florence and Schrader, Christina and Pons, Monica and Socha, Piotr and Krag, Aleksander and Sturm, Ekkehard and Bouchecareilh, Marion and Strnad, Pavel},
title = {Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency},
journal = {Seminars in Liver Disease},
year = {2023},
volume = {43},
number = {03},
pages = {258--266},
doi = {10.1055/a-2122-7674}
}
EUVIMED